Table 2. Immunophenotyping results... | Rockefeller University Press

Table 2.

Immunophenotyping results

Immune cell type	Surface marker	Time point	Low	Normal	High
B cells	CD19	Diagnosis	8 (44%)	9 (50%)	1 (6%)
B cells	CD19	Last follow-up	4 (29%)	10 (71%)	0 (0%)
T cells	CD3	Diagnosis	11 (61%)	7 (39%)	0 (0%)
T cells	CD3	Last follow-up	5 (38%)	8 (62%)	0 (0%)
T helper cells	CD3 CD4	Diagnosis	6 (33%)	10 (56%)	2 (11%)
T helper cells	CD3 CD4	Last follow-up	5 (38%)	7 (54%)	1 (8%)
T killer cells	CD3 CD8	Diagnosis	10 (56%)	8 (44%)	0 (0%)
T killer cells	CD3 CD8	Last follow-up	5 (38%)	7 (54%)	1 (8%)
NK cells	CD56	Diagnosis	9 (50%)	9 (50%)	0 (0%)
NK cells	CD56	Last follow-up	3 (23%)	10 (77%)	0 (0%)

Immune cell type	Surface marker	Time point	Low	Normal	High
B cells	CD19	Diagnosis	8 (44%)	9 (50%)	1 (6%)
B cells	CD19	Last follow-up	4 (29%)	10 (71%)	0 (0%)
T cells	CD3	Diagnosis	11 (61%)	7 (39%)	0 (0%)
T cells	CD3	Last follow-up	5 (38%)	8 (62%)	0 (0%)
T helper cells	CD3 CD4	Diagnosis	6 (33%)	10 (56%)	2 (11%)
T helper cells	CD3 CD4	Last follow-up	5 (38%)	7 (54%)	1 (8%)
T killer cells	CD3 CD8	Diagnosis	10 (56%)	8 (44%)	0 (0%)
T killer cells	CD3 CD8	Last follow-up	5 (38%)	7 (54%)	1 (8%)
NK cells	CD56	Diagnosis	9 (50%)	9 (50%)	0 (0%)
NK cells	CD56	Last follow-up	3 (23%)	10 (77%)	0 (0%)

Results are given for the time point of diagnosis and at last follow-up with absolute numbers and relative percentages in parentheses. Since immunophenotyping results were not available for all patients, the percentages correspond to the total number of patients for whom a certain phenotyping result was available. Normal values were used according to Comans-Bitter et al. (17).

[ViewLarge]

Sharing Unavailable